{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:51:06Z","timestamp":1791406266889,"version":"4.3.3"},"reference-count":237,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.addr.2015.06.008","type":"journal-article","created":{"date-parts":[[2015,7,4]],"date-time":"2015-07-04T18:08:42Z","timestamp":1436033322000},"page":"105-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":190,"special_numbering":"C","title":["New strategies for local treatment of vaginal infections"],"prefix":"10.1016","volume":"92","author":[{"given":"Rita","family":"Palmeira-de-Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Palmeira-de-Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Martinez-de-Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2015.06.008_bb0005","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.bpobgyn.2007.01.002","article-title":"Definition and classification of abnormal vaginal flora","volume":"21","author":"Donders","year":"2007","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.addr.2015.06.008_bb0010","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1258\/095646202760159639","article-title":"Facts and myths on recurrent vulvovaginal candidosis\u2014a review on epidemiology, clinical manifestations, diagnosis, pathogenesis and therapy","volume":"13","author":"Mardh","year":"2002","journal-title":"Int. J. STD AIDS"},{"key":"10.1016\/j.addr.2015.06.008_bb0015","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.contraception.2005.12.007","article-title":"Attitudes, perceptions and knowledge about the vagina: the International Vagina Dialogue Survey","volume":"73","author":"Nappi","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.addr.2015.06.008_bb0020","first-page":"1","article-title":"Women's experiences, preferences and perceptions regarding vaginal products: results from a cross-sectional web-based survey in Portugal","author":"Palmeira-de-Oliveira","year":"2014","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"key":"10.1016\/j.addr.2015.06.008_bb0025","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0277-9536(02)00092-8","article-title":"The vaginitis monologues: women's experiences of vaginal complaints in a primary care setting","volume":"56","author":"Karasz","year":"2003","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.addr.2015.06.008_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074378","article-title":"The burden of bacterial vaginosis: women's experience of the physical, emotional, sexual and social impact of living with recurrent bacterial vaginosis","volume":"8","author":"Bilardi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2015.06.008_bb0035","series-title":"Mucoadhesive Materials and Drug Delivery Systems","first-page":"99","article-title":"Vaginal mucosa and drug delivery","author":"das Neves","year":"2014"},{"key":"10.1016\/j.addr.2015.06.008_bb0040","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0010-7824(99)00010-4","article-title":"A vaginal fluid simulant","volume":"59","author":"Owen","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.addr.2015.06.008_bb0045","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/infdis\/jiu231","article-title":"Human alpha-amylase present in lower-genital-tract mucosal fluid processes glycogen to support vaginal colonization by Lactobacillus","volume":"210","author":"Spear","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.addr.2015.06.008_bb0050","series-title":"The History of Medications for Women: Materia Medica Woman","author":"O'Dowd","year":"2001"},{"key":"10.1016\/j.addr.2015.06.008_bb0055","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1461-5347(00)00296-0","article-title":"The scope and potential of vaginal drug delivery","volume":"3","author":"Vermani","year":"2000","journal-title":"Pharm. Sci. Technol. Today"},{"key":"10.1016\/j.addr.2015.06.008_bb0060","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jconrel.2004.11.034","article-title":"The vagina as a route for systemic drug delivery","volume":"103","author":"Hussain","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.06.008_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2006.03.012","article-title":"Gels as vaginal drug delivery systems","volume":"318","author":"das Neves","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2015.06.008_bb0070","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2174\/187221109789105658","article-title":"Mucoadhesive vaginal drug delivery systems","volume":"3","author":"Acarturk","year":"2009","journal-title":"Recent Pat. Drug Deliv. Formul."},{"key":"10.1016\/j.addr.2015.06.008_bb0075","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.addr.2005.07.004","article-title":"The use of mucoadhesive polymers in vaginal delivery","volume":"57","author":"Valenta","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2015.06.008_bb0080","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1128\/AAC.48.9.3291-3297.2004","article-title":"Penetration of Candida biofilms by antifungal agents","volume":"48","author":"Al-Fattani","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2015.06.008_bb0085","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1128\/EC.4.4.633-638.2005","article-title":"Candida biofilms: an update","volume":"4","author":"Ramage","year":"2005","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.addr.2015.06.008_bb0090","first-page":"e171","article-title":"Effect of biofilm phenotype on resistance of Gardnerella vaginalis to hydrogen peroxide and lactic acid","volume":"170","author":"Patterson","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.addr.2015.06.008_bb0095","first-page":"e91","article-title":"An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole","volume":"97","author":"Swidsinski","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.addr.2015.06.008_bb0100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1155\/S1064744901000047","article-title":"Vaginal microflora associated with bacterial vaginosis in nonpregnant women: reliability of sialidase detection","volume":"9","author":"Smayevsky","year":"2001","journal-title":"Infect. Dis. Obstet. Gynecol."},{"key":"10.1016\/j.addr.2015.06.008_bb0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2334-4-5","article-title":"Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis","volume":"4","author":"Ferris","year":"2004","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.addr.2015.06.008_bb0110","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2180-4-16","article-title":"Cloning of 16S rRNA genes amplified from normal and disturbed vaginal microflora suggests a strong association between Atopobium vaginae, Gardnerella vaginalis and bacterial vaginosis","volume":"4","author":"Verhelst","year":"2004","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.addr.2015.06.008_bb0115","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMoa043802","article-title":"Molecular identification of bacteria associated with bacterial vaginosis","volume":"353","author":"Fredricks","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2015.06.008_bb0120","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10096-008-0617-0","article-title":"Quantitative variations in the vaginal bacterial population associated with asymptomatic infections: a real-time polymerase chain reaction study","volume":"28","author":"Biagi","year":"2009","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.addr.2015.06.008_bb0125","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1086\/428288","article-title":"Factors associated with absence of H2O2-producing Lactobacillus among women with bacterial vaginosis","volume":"191","author":"Beigi","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.addr.2015.06.008_bb0130","first-page":"194","article-title":"Bacterial vaginosis and candidosis","volume":"7","author":"Martinez Oliveira","year":"1993","journal-title":"Arq. Med."},{"key":"10.1016\/j.addr.2015.06.008_bb0135","doi-asserted-by":"crossref","first-page":"553","DOI":"10.7326\/0003-4819-111-7-553","article-title":"Style notes: bacterial vaginosis or vaginal bacteriosis?","volume":"111","author":"Huth","year":"1989","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.addr.2015.06.008_bb0140","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/0002-9378(55)90095-8","article-title":"Haemophilus vaginalis vaginitis: a newly defined specific infection previously classified non-specific vaginitis","volume":"69","author":"Gardner","year":"1955","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.addr.2015.06.008_bb0145","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev.med.51.1.349","article-title":"Bacterial vaginosis","volume":"51","author":"Sobel","year":"2000","journal-title":"Annu. Rev. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.addr.2015.06.008_bb0150","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/S0020-7292(99)00133-2","article-title":"The epidemiology of bacterial vaginosis","volume":"67","author":"Schmid","year":"1999","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.addr.2015.06.008_bb0155","volume":"vol. 59, No. RR-12","author":"C.D.C. Centers for Disease Control and Prevention","year":"2010"},{"key":"10.1016\/j.addr.2015.06.008_bb0160","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/01.OLQ.0000129948.91055.9F","article-title":"Predictors of bacterial vaginosis in adolescent women who douche","volume":"31","author":"Schwebke","year":"2004","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.addr.2015.06.008_bb0165","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1086\/423963","article-title":"Bacterial vaginosis and anaerobic bacteria are associated with endometritis","volume":"39","author":"Haggerty","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.addr.2015.06.008_bb0170","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/bmj.308.6924.295","article-title":"Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage","volume":"308","author":"Hay","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.addr.2015.06.008_bb0175","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1128\/CMR.4.4.485","article-title":"Bacterial vaginosis","volume":"4","author":"Spiegel","year":"1991","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.addr.2015.06.008_bb0180","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0002-9343(83)91112-9","article-title":"Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations","volume":"74","author":"Amsel","year":"1983","journal-title":"Am. J. Med."},{"key":"10.1016\/j.addr.2015.06.008_bb0185","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1128\/JCM.29.2.297-301.1991","article-title":"Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation","volume":"29","author":"Nugent","year":"1991","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.addr.2015.06.008_bb0190","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1128\/AEM.01251-07","article-title":"Dynamics of vaginal bacterial communities in women developing bacterial vaginosis, candidiasis, or no infection, analyzed by PCR-denaturing gradient gel electrophoresis and real-time PCR","volume":"73","author":"Vitali","year":"2007","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.addr.2015.06.008_bb0195","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1128\/JCM.18.2.344-347.1983","article-title":"Semiquantitative culture of Gardnerella vaginalis in laboratory determination of nonspecific vaginitis","volume":"18","author":"Ratnam","year":"1983","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.addr.2015.06.008_bb0200","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/infdis\/jiu131","article-title":"Gardnerella vaginalis outcompetes 29 other bacterial species isolated from patients with bacterial vaginosis, using in an in vitro biofilm formation model","volume":"210","author":"Alves","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.addr.2015.06.008_bb0205","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1099\/mic.0.034280-0","article-title":"Analysis of adherence, biofilm formation and cytotoxicity suggests a greater virulence potential of Gardnerella vaginalis relative to other bacterial-vaginosis-associated anaerobes","volume":"156","author":"Patterson","year":"2010","journal-title":"Microbiology"},{"key":"10.1016\/j.addr.2015.06.008_bb0210","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00007435-200303000-00016","article-title":"Glycosidase and proteinase activity of anaerobic gram-negative bacteria isolated from women with bacterial vaginosis","volume":"30","author":"Olmsted","year":"2003","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.addr.2015.06.008_bb0215","first-page":"443","article-title":"Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream","volume":"41","author":"Ferris","year":"1995","journal-title":"J. Fam. Pract."},{"key":"10.1016\/j.addr.2015.06.008_bb0220","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000239537","article-title":"Comparative study on vaginal or oral treatment of bacterial vaginosis","volume":"43","author":"Mikamo","year":"1997","journal-title":"Chemotherapy"},{"key":"10.1016\/j.addr.2015.06.008_bb0225","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1086\/503780","article-title":"High recurrence rates of bacterial vaginosis over the course of 12months after oral metronidazole therapy and factors associated with recurrence","volume":"193","author":"Bradshaw","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.addr.2015.06.008_bb0230","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1128\/JCM.43.9.4492-4497.2005","article-title":"Microbiologic response to treatment of bacterial vaginosis with topical clindamycin or metronidazole","volume":"43","author":"Austin","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.addr.2015.06.008_bb0235","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ajog.2004.05.033","article-title":"Antimicrobial resistance associated with the treatment of bacterial vaginosis","volume":"191","author":"Beigi","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.addr.2015.06.008_bb0240","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1471-0528.2002.00432.x","article-title":"Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis","volume":"109","author":"Donders","year":"2002","journal-title":"BJOG"},{"key":"10.1016\/j.addr.2015.06.008_bb0245","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s10096-013-1846-4","article-title":"Prevalence and treatment of aerobic vaginitis among non-pregnant women: evaluation of the evidence for an underestimated clinical entity","volume":"32","author":"Tansarli","year":"2013","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.addr.2015.06.008_bb0250","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijantimicag.2003.12.013","article-title":"Microbiological\/clinical characteristics and validation of topical therapy with kanamycin in aerobic vaginitis: a pilot study","volume":"24","author":"Tempera","year":"2004","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.addr.2015.06.008_bb0255","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0002-9378(85)80003-X","article-title":"Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis","volume":"152","author":"Sobel","year":"1985","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.addr.2015.06.008_bb0260","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/pgmj.55.647.645","article-title":"Candida vaginitis","volume":"55","author":"Hurley","year":"1979","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.addr.2015.06.008_bb0265","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1089\/jwh.1998.7.1167","article-title":"Frequency and response to vaginal symptoms among white and African American women: results of a random digit dialing survey","volume":"7","author":"Foxman","year":"1998","journal-title":"J. Women's Health"},{"key":"10.1016\/j.addr.2015.06.008_bb0270","first-page":"757","article-title":"Vulvovaginal candidiasis: clinical manifestations, risk factors, management algorithm","volume":"92","author":"Eckert","year":"1998","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.addr.2015.06.008_bb0275","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/S0140-6736(07)60917-9","article-title":"Vulvovaginal candidosis","volume":"369","author":"Sobel","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2015.06.008_bb0280","series-title":"Theory and Practice","article-title":"Vulvovaginal candidosis","author":"Mendling","year":"1988"},{"key":"10.1016\/j.addr.2015.06.008_bb0285","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1749-6632.1988.tb40450.x","article-title":"Pathogenesis and epidemiology of vulvovaginal candidiasis","volume":"544","author":"Sobel","year":"1988","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.addr.2015.06.008_bb0290","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1067\/mob.2002.125280","article-title":"Antimicrobial components of vaginal fluid","volume":"187","author":"Valore","year":"2002","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.addr.2015.06.008_bb0295","first-page":"7","article-title":"Human genital candidiasis: histochemistry, scanning and transmission electron microscopy","volume":"26","author":"Garcia-Tamayo","year":"1982","journal-title":"Acta Cytol."},{"key":"10.1016\/j.addr.2015.06.008_bb0300","doi-asserted-by":"crossref","first-page":"e807","DOI":"10.1111\/j.1439-0507.2011.02030.x","article-title":"Recurrent vulvovaginal candidosis: focus on the vulva","volume":"54","author":"Beikert","year":"2011","journal-title":"Mycoses"},{"key":"10.1016\/j.addr.2015.06.008_bb0305","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/sti.77.3.179","article-title":"An investigation into the pathogenesis of vulvo-vaginal candidosis","volume":"77","author":"El-Din","year":"2001","journal-title":"Sex. Transm. Infect."},{"key":"10.1016\/j.addr.2015.06.008_bb0310","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1471-0528.2003.01445.x","article-title":"Colonisation of extragenital sites by Candida in women with recurrent vulvovaginal candidosis","volume":"110","author":"Mardh","year":"2003","journal-title":"BJOG"},{"key":"10.1016\/j.addr.2015.06.008_bb0315","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1128\/CMR.9.3.335","article-title":"Immunopathogenesis of recurrent vulvovaginal candidiasis","volume":"9","author":"Fidel","year":"1996","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.addr.2015.06.008_bb0320","doi-asserted-by":"crossref","first-page":"5385","DOI":"10.1128\/JB.183.18.5385-5394.2001","article-title":"Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance","volume":"183","author":"Chandra","year":"2001","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.addr.2015.06.008_bb0325","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/jac\/dkh071","article-title":"Susceptibility of Candida albicans biofilms grown in a constant depth film fermentor to chlorhexidine, fluconazole and miconazole: a longitudinal study","volume":"53","author":"Lamfon","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.addr.2015.06.008_bb0330","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1086\/380796","article-title":"Guidelines for treatment of candidiasis","volume":"38","author":"Pappas","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.addr.2015.06.008_bb0335","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000314022","article-title":"Management of recurrent vulvo-vaginal candidosis as a chronic illness","volume":"70","author":"Donders","year":"2010","journal-title":"Gynecol. Obstet. Investig."},{"key":"10.1016\/j.addr.2015.06.008_bb0340","doi-asserted-by":"crossref","first-page":"613.e1","DOI":"10.1016\/j.ajog.2008.06.029","article-title":"Individualized decreasing-dose maintenance fluconazole regimen for recurrent vulvovaginal candidiasis (ReCiDiF trial)","volume":"199","author":"Donders","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.addr.2015.06.008_bb0345","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2337\/dc06-1469","article-title":"Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis","volume":"30","author":"Ray","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.addr.2015.06.008_bb0350","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1067\/mob.2001.115116","article-title":"Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole","volume":"185","author":"Sobel","year":"2001","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.addr.2015.06.008_bb0355","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.diagmicrobio.2009.03.021","article-title":"Reduced fluconazole susceptibility of Candida albicans isolates in women with recurrent vulvovaginal candidiasis: effects of long-term fluconazole therapy","volume":"64","author":"Shahid","year":"2009","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.addr.2015.06.008_bb0360","series-title":"Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections Overview and Estimates","author":"W. World Health Organization","year":"2001"},{"key":"10.1016\/j.addr.2015.06.008_bb0365","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1086\/522532","article-title":"The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001\u20132004","volume":"45","author":"Sutton","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.addr.2015.06.008_bb0370","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/clinids\/23.5.1075","article-title":"Clinical and microbiological correlates of vaginal trichomoniasis during pregnancy. The Vaginal Infections and Prematurity Study Group","volume":"23","author":"Pastorek","year":"1996","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.addr.2015.06.008_bb0375","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00001432-200002000-00007","article-title":"Biology of trichomonosis","volume":"13","author":"Lehker","year":"2000","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.addr.2015.06.008_bb0380","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1128\/IAI.68.9.4907-4912.2000","article-title":"CP30, a cysteine proteinase involved in Trichomonas vaginalis cytoadherence","volume":"68","author":"Mendoza-Lopez","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2015.06.008_bb0385","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.0141-9838.2004.00690.x","article-title":"Monoclonal antibodies against a 62kDa proteinase of Trichomonas vaginalis decrease parasite cytoadherence to epithelial cells and confer protection in mice","volume":"26","author":"Hernandez","year":"2004","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.addr.2015.06.008_bb0390","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/sextrans-2013-051052","article-title":"The villain team-up or how Trichomonas vaginalis and bacterial vaginosis alter innate immunity in concert","volume":"89","author":"Fichorova","year":"2013","journal-title":"Sex. Transm. Infect."},{"key":"10.1016\/j.addr.2015.06.008_bb0395","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000218","article-title":"Interventions for treating trichomoniasis in women","author":"Forna","year":"2003","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.addr.2015.06.008_bb0400","first-page":"545","article-title":"Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic","volume":"46","author":"Schmid","year":"2001","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.addr.2015.06.008_bb0405","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1128\/AAC.00814-06","article-title":"Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole","volume":"50","author":"Schwebke","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2015.06.008_bb0410","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1128\/CMR.11.2.300","article-title":"Clinical and microbiological aspects of Trichomonas vaginalis","volume":"11","author":"Petrin","year":"1998","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.addr.2015.06.008_bb0415","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0378-5173(02)00232-6","article-title":"Rheological evaluation of thermosensitive and mucoadhesive vaginal gels in physiological conditions","volume":"241","author":"Chang","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2015.06.008_bb0420","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0010-7824(02)00430-4","article-title":"Effect of temperature and pH on contraceptive gel viscosity","volume":"67","author":"Owen","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.addr.2015.06.008_bb0425","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ejpb.2010.07.004","article-title":"Formulation of mucoadhesive vaginal hydrogels insensitive to dilution with vaginal fluids","volume":"76","author":"Aka-Any-Grah","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2015.06.008_bb0430","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1002\/jps.21192","article-title":"Effects of physiological fluids on physical\u2013chemical characteristics and activity of topical vaginal microbicide products","volume":"97","author":"Sassi","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2015.06.008_bb0435","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.colsurfb.2012.10.038","article-title":"Development of a novel synergistic thermosensitive gel for vaginal candidiasis: an in vitro, in vivo evaluation","volume":"103","author":"Mirza","year":"2013","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.addr.2015.06.008_bb0440","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1208\/s12249-009-9233-2","article-title":"Microemulsion-based vaginal gel of clotrimazole: formulation, in vitro evaluation, and stability studies","volume":"10","author":"Bachhav","year":"2009","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.addr.2015.06.008_bb0445","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijpharm.2008.08.021","article-title":"Microemulsion based vaginal gel of fluconazole: formulation, in vitro and in vivo evaluation","volume":"365","author":"Bachhav","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2015.06.008_bb0450","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijbiomac.2014.05.033","article-title":"Bioadhesive tablets containing cyclodextrin complex of itraconazole for the treatment of vaginal candidiasis","volume":"69","author":"Cevher","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.addr.2015.06.008_bb0455","doi-asserted-by":"crossref","DOI":"10.1208\/ps050105","article-title":"A mucoadhesive, cyclodextrin-based vaginal cream formulation of itraconazole","volume":"5","author":"Francois","year":"2003","journal-title":"AAPS PharmSci"},{"key":"10.1016\/j.addr.2015.06.008_bb0460","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1016\/j.jconrel.2006.09.075","article-title":"Thermosensitive vaginal gel formulation for the controlled release of clotrimazole via complexation to beta-cyclodextrin","volume":"116","author":"Bilensoy","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.06.008_bb0465","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ejps.2010.07.009","article-title":"A thermosensitive vaginal gel formulation with HPgammaCD for the pH-dependent release and solubilization of amphotericin B","volume":"41","author":"Kim","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2015.06.008_bb0470","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0169-409X(00)00103-4","article-title":"Microemulsion-based media as novel drug delivery systems","volume":"45","author":"Lawrence","year":"2000","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2015.06.008_bb0475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v14.i1.10","article-title":"Cyclodextrins\u2014enabling excipients: their present and future use in pharmaceuticals","volume":"14","author":"Thompson","year":"1997","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.addr.2015.06.008_bb0480","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0015-0282(01)01822-2","article-title":"Distribution of topical medication in the human vagina as imaged by magnetic resonance imaging","volume":"76","author":"Barnhart","year":"2001","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.addr.2015.06.008_bb0485","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1023\/A:1012113714552","article-title":"Spreading and retention of vaginal formulations in post-menopausal women as assessed by gamma scintigraphy","volume":"14","author":"Brown","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2015.06.008_bb0490","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.contraception.2004.06.013","article-title":"In vivo distribution of a vaginal gel: MRI evaluation of the effects of gel volume, time and simulated intercourse","volume":"70","author":"Barnhart","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.addr.2015.06.008_bb0495","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1701-2163(15)30682-4","article-title":"Universal vaginal applicator for the uniform distribution of vaginal gel and cream formulations: a magnetic resonance imaging study","volume":"36","author":"Omar","year":"2014","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.addr.2015.06.008_bb0500","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.addr.2005.07.001","article-title":"The basics and underlying mechanisms of mucoadhesion","volume":"57","author":"Smart","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2015.06.008_bb0505","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2478\/v10007-008-0023-2","article-title":"Development and in vitro evaluation of an acid buffering bioadhesive vaginal gel for mixed vaginal infections","volume":"58","author":"Ahmad","year":"2008","journal-title":"Acta Pharma."},{"key":"10.1016\/j.addr.2015.06.008_bb0510","doi-asserted-by":"crossref","DOI":"10.1208\/pt0804109","article-title":"Development and evaluation of acid-buffering bioadhesive vaginal tablet for mixed vaginal infections","volume":"8","author":"Alam","year":"2007","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.addr.2015.06.008_bb0515","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0168-3659(02)00077-9","article-title":"Design and in vitro evaluation of a novel bioadhesive vaginal drug delivery system for clotrimazole","volume":"81","author":"Kast","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.06.008_bb0520","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1248\/cpb.c13-00689","article-title":"Vaginal chitosan tablets with clotrimazole-design and evaluation of mucoadhesive properties using porcine vaginal mucosa, mucin and gelatine","volume":"62","author":"Szymanska","year":"2014","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.addr.2015.06.008_bb0525","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1081\/DDC-100105179","article-title":"Development of a mucoadhesive dosage form for vaginal administration","volume":"27","author":"Cecshel","year":"2001","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.addr.2015.06.008_bb0530","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1248\/cpb.59.952","article-title":"In vitro evaluation of mucoadhesive vaginal tablets of antifungal drugs prepared with thiolated polymer and development of a new dissolution technique for vaginal formulations","volume":"59","author":"Baloglu","year":"2011","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.addr.2015.06.008_bb0535","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijpharm.2007.08.042","article-title":"A novel ketoconazole bioadhesive effervescent tablet for vaginal delivery: design, in vitro and \u2018in vivo\u2019 evaluation","volume":"350","author":"Wang","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2015.06.008_bb0540","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/jps.21457","article-title":"Development and in vitro evaluation of a mucoadhesive vaginal delivery system for nystatin","volume":"98","author":"Hombach","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2015.06.008_bb0545","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.colsurfb.2008.06.005","article-title":"Chitosan and a modified chitosan as agents to improve performances of mucoadhesive vaginal gels","volume":"66","author":"Perioli","year":"2008","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.addr.2015.06.008_bb0550","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ijpharm.2009.05.016","article-title":"FG90 chitosan as a new polymer for metronidazole mucoadhesive tablets for vaginal administration","volume":"377","author":"Perioli","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2015.06.008_bb0555","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0301-2115(02)00110-0","article-title":"Local treatment of bacterial vaginosis with a bioadhesive metronidazole tablet","volume":"105","author":"Voorspoels","year":"2002","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.addr.2015.06.008_bb0560","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.carbpol.2012.08.074","article-title":"Chitosan\/alginate complexes for vaginal delivery of chlorhexidine digluconate","volume":"91","author":"Abruzzo","year":"2013","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.addr.2015.06.008_bb0565","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ijpharm.2014.12.008","article-title":"Vaginal inserts based on chitosan and carboxymethylcellulose complexes for local delivery of chlorhexidine: preparation, characterization and antimicrobial activity","volume":"478","author":"Bigucci","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2015.06.008_bb0570","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1080\/03639040802592435","article-title":"Formulation studies of benzydamine mucoadhesive formulations for vaginal administration","volume":"35","author":"Perioli","year":"2009","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.addr.2015.06.008_bb0575","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/sti.2002.002733","article-title":"Managing recurrent bacterial vaginosis","volume":"80","author":"Wilson","year":"2004","journal-title":"Sex. Transm. Infect."},{"key":"10.1016\/j.addr.2015.06.008_bb0580","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1517\/14656566.2014.881800","article-title":"Treatment of bacterial vaginosis: what we have and what we miss","volume":"15","author":"Donders","year":"2014","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.addr.2015.06.008_bb0585","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0168-3659(94)90156-2","article-title":"Vaginal and reproductive system treatments using a bioadhesive polymer","volume":"28","author":"Robinson","year":"1994","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.06.008_bb0590","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0011-393X(00)90004-3","article-title":"Effect on vaginal pH of a polycarbophil vaginal gel compared with an acidic douche in women with suspected bacterial vaginosis: a randomized, controlled study","volume":"2000","author":"Milani","year":"2000","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"10.1016\/j.addr.2015.06.008_bb0595","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejogrb.2004.10.011","article-title":"Successful treatment of bacterial vaginosis with a policarbophil\u2013carbopol acidic vaginal gel: results from a randomised double-blind, placebo-controlled trial","volume":"120","author":"Fiorilli","year":"2005","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.addr.2015.06.008_bb0600","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0010-7824(01)00217-7","article-title":"Properties of a new acid-buffering bioadhesive vaginal formulation (ACIDFORM)","volume":"64","author":"Garg","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.addr.2015.06.008_bb0605","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.contraception.2014.01.015","article-title":"ACIDFORM: a review of the evidence","volume":"90","author":"Bayer","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.addr.2015.06.008_bb0610","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2125.2005.02550.x","article-title":"A pilot clinical trial comparing an acid-buffering formulation (ACIDFORM gel) with metronidazole gel for the treatment of symptomatic bacterial vaginosis","volume":"61","author":"Simoes","year":"2006","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.addr.2015.06.008_bb0615","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.msec.2014.08.026","article-title":"Preparation and characterization of novel carbopol based bigels for topical delivery of metronidazole for the treatment of bacterial vaginosis","volume":"44","author":"Singh","year":"2014","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.addr.2015.06.008_bb0620","doi-asserted-by":"crossref","first-page":"312","DOI":"10.18433\/J3HP41","article-title":"Strategies to prolong the intravaginal residence time of drug delivery systems","volume":"12","author":"Baloglu","year":"2009","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.addr.2015.06.008_bb0625","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000298923","article-title":"Treatment of bacterial vaginosis with an acid cream: a comparison between the effect of lactate-gel and metronidazole","volume":"21","author":"Andersch","year":"1986","journal-title":"Gynecol. Obstet. Investig."},{"key":"10.1016\/j.addr.2015.06.008_bb0630","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1055\/s-0031-1296197","article-title":"Efficacy of vitamin C vaginal tablets in the treatment of bacterial vaginosis: a randomised, double blind, placebo controlled clinical trial","volume":"61","author":"Petersen","year":"2011","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.addr.2015.06.008_bb0635","first-page":"309","article-title":"Efficacy of vitamin C vaginal tablets as prophylaxis for recurrent bacterial vaginosis: a randomised, double-blind, placebo-controlled clinical trial","volume":"5","author":"Krasnopolsky","year":"2013","journal-title":"J. Clin. Med. Res."},{"key":"10.1016\/j.addr.2015.06.008_bb0640","first-page":"484","article-title":"Comparison of the effectiveness of vitamin C vaginal tablet with metronidazole vaginal gel in the treatment of bacterial vaginosis","volume":"4","author":"Abbaspoor","year":"2010","journal-title":"Afr. J. Pharm. Pharmacol."},{"key":"10.1016\/j.addr.2015.06.008_bb0645","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/01.OLQ.0000118423.20985.E7","article-title":"A randomized, double-blind clinical trial of vaginal acidification versus placebo for the treatment of symptomatic bacterial vaginosis","volume":"31","author":"Holley","year":"2004","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.addr.2015.06.008_bb0650","first-page":"388","article-title":"Effect of lactic acid suppositories compared with oral metronidazole and placebo in bacterial vaginosis: a randomised clinical trial","volume":"69","author":"Boeke","year":"1993","journal-title":"Genitourin. Med."},{"key":"10.1016\/j.addr.2015.06.008_bb0655","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1208\/pt0704104","article-title":"Chitosan gels for the vaginal delivery of lactic acid: relevance of formulation parameters to mucoadhesion and release mechanisms","volume":"7","author":"Bonferoni","year":"2006","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.addr.2015.06.008_bb0660","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ejps.2003.10.028","article-title":"Assessment of chitosan derivatives as buccal and vaginal penetration enhancers","volume":"21","author":"Sandri","year":"2004","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2015.06.008_bb0665","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0378-5173(99)00030-7","article-title":"Effect of chitosan on epithelial permeability and structure","volume":"182","author":"Dodane","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2015.06.008_bb0670","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1211\/jpp.58.8.0002","article-title":"Advances and potential applications of chitosan derivatives as mucoadhesive biomaterials in modern drug delivery","volume":"58","author":"Chopra","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.addr.2015.06.008_bb0675","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000314023","article-title":"Anti-Candida activity of a chitosan hydrogel: mechanism of action and cytotoxicity profile","volume":"70","author":"Palmeira-de-Oliveira","year":"2010","journal-title":"Gynecol. Obstet. Investig."},{"key":"10.1016\/j.addr.2015.06.008_bb0680","first-page":"139","article-title":"Antifungal effect of high- and low-molecular-weight chitosan hydrochloride, carboxymethyl chitosan, chitosan oligosaccharide and N-acetyl-d-glucosamine against Candida albicans, Candida krusei and Candida glabrata","volume":"353","author":"Seyfarth","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2015.06.008_bb0685","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1021\/bm034130m","article-title":"Chitosan as antimicrobial agent: applications and mode of action","volume":"4","author":"Rabea","year":"2003","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2015.06.008_bb0690","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0378-5173(92)90259-5","article-title":"Simple tests demonstrating the antimycotic effect of chitosan","volume":"80","author":"Knapczyk","year":"1992","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2015.06.008_bb0695","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/ffj.3144","article-title":"Association of Thymbra capitata essential oil and chitosan (TCCH hydrogel): a putative therapeutic tool for the treatment of vulvovaginal candidosis","volume":"28","author":"Palmeira-de-Oliveira","year":"2013","journal-title":"Flavour Fragr. J."},{"key":"10.1016\/j.addr.2015.06.008_bb0700","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1002\/jps.23571","article-title":"Ability of chitosan gels to disrupt bacterial biofilms and their applications in the treatment of bacterial vaginosis","volume":"102","author":"Kandimalla","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2015.06.008_bb0705","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00430-013-0311-4","article-title":"Anti-biofilm activity of low-molecular weight chitosan hydrogel against Candida species","volume":"203","author":"Silva-Dias","year":"2014","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.addr.2015.06.008_bb0710","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/1471-2334-12-148","article-title":"Antiseptics and disinfectants for the treatment of bacterial vaginosis: a systematic review","volume":"12","author":"Verstraelen","year":"2012","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.addr.2015.06.008_bb0715","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000321047","article-title":"Antimicrobial topical agents used in the vagina","volume":"40","author":"Frey Tirri","year":"2011","journal-title":"Curr. Probl. Dermatol."},{"key":"10.1016\/j.addr.2015.06.008_bb0720","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1185\/030079904125003692","article-title":"Efficacy and tolerability of a new chlorhexidine-based vaginal gel in vaginal infections","volume":"20","author":"Molteni","year":"2004","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.addr.2015.06.008_bb0725","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.3109\/03639045.2012.723217","article-title":"Vaginal distribution and retention of tablets comprising starch-based multiparticulates: evaluation by colposcopy","volume":"39","author":"Mehta","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.addr.2015.06.008_bb0730","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1002\/jps.23577","article-title":"Vaginal films for drug delivery","volume":"102","author":"Machado","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2015.06.008_bb0735","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1208\/s12248-009-9082-7","article-title":"Vaginal drug delivery systems for HIV prevention","volume":"11","author":"Rohan","year":"2009","journal-title":"AAPS J."},{"key":"10.1016\/j.addr.2015.06.008_bb0740","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1208\/s12249-009-9288-0","article-title":"A novel itraconazole bioadhesive film for vaginal delivery: design, optimization, and physicodynamic characterization","volume":"10","author":"Dobaria","year":"2009","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.addr.2015.06.008_bb0745","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3109\/10837450903262058","article-title":"Design and in vitro evaluation of a novel bioadhesive vaginal drug delivery system for clindamycin phosphate","volume":"15","author":"Dobaria","year":"2010","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.addr.2015.06.008_bb0750","first-page":"585","article-title":"Preparation and characterisation of fluconazole vaginal films for the treatment of vaginal candidiasis","volume":"75","author":"Kumar","year":"2013","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.addr.2015.06.008_bb0755","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/jps.20752","article-title":"Temperature and pH sensitive hydrogels: an approach towards smart semen-triggered vaginal microbicidal vehicles","volume":"96","author":"Gupta","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2015.06.008_bb0760","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ejpb.2011.06.007","article-title":"pH-responsive nanoparticles releasing tenofovir intended for the prevention of HIV transmission","volume":"79","author":"Zhang","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2015.06.008_bb0765","first-page":"339","article-title":"Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations","volume":"9","author":"Escobar-Chavez","year":"2006","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.addr.2015.06.008_bb0770","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0168-3659(02)00086-X","article-title":"Prolonged antifungal effects of clotrimazole-containing mucoadhesive thermosensitive gels on vaginitis","volume":"82","author":"Chang","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.06.008_bb0775","doi-asserted-by":"crossref","DOI":"10.1208\/pt070238","article-title":"Mucoadhesive, thermosensitive, prolonged-release vaginal gel for clotrimazole:\u03b2-cyclodextrin complex","volume":"7","author":"Bilensoy","year":"2006","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.addr.2015.06.008_bb0780","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1111\/j.2042-7158.2011.01315.x","article-title":"In-situ gel formulations of econazole nitrate: preparation and in-vitro and in-vivo evaluation","volume":"63","author":"Baloglu","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.addr.2015.06.008_bb0785","doi-asserted-by":"crossref","first-page":"417","DOI":"10.4236\/pp.2012.34056","article-title":"A new in-situ gel formulation of itraconazole for vaginal administration","volume":"3","author":"Karavana","year":"2012","journal-title":"Pharmacol. Pharm."},{"key":"10.1016\/j.addr.2015.06.008_bb0790","first-page":"358","article-title":"Development of miconazole nitrate thermosensitive bioadhesive vaginal gel for vaginal candidiasis","volume":"3","author":"Hani","year":"2013","journal-title":"Am. J. Adv. Drug Deliv."},{"key":"10.1016\/j.addr.2015.06.008_bb0795","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3109\/10611861003649712","article-title":"A new vaginal delivery system of amphotericin B: a dispersion of cationic liposomes in a thermosensitive gel","volume":"18","author":"Kang","year":"2010","journal-title":"J. Drug Target."},{"key":"10.1016\/j.addr.2015.06.008_bb0800","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2478\/v10007-012-0009-y","article-title":"Development and characterization of thermosensitive pluronic-based metronidazole in situ gelling formulations for vaginal application","volume":"62","author":"Ibrahim","year":"2012","journal-title":"Acta Pharma."},{"key":"10.1016\/j.addr.2015.06.008_bb0805","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1447-0756.2010.01457.x","article-title":"Pilot randomized trial for treatment of bacterial vaginosis using in situ forming metronidazole vaginal gel","volume":"37","author":"Shaaban","year":"2011","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.addr.2015.06.008_bb0810","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ejpb.2004.03.019","article-title":"In situ-forming hydrogels\u2014review of temperature-sensitive systems","volume":"58","author":"Ruel-Gariepy","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2015.06.008_bb0815","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3109\/03639045.2012.762654","article-title":"Comparison of poloxamer- and chitosan-based thermally sensitive gels for the treatment of vaginal mucositis","volume":"40","author":"Rossi","year":"2014","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.addr.2015.06.008_bb0820","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jconrel.2014.04.033","article-title":"Nanoparticle-based drug delivery to the vagina: a review","volume":"190","author":"Ensign","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.06.008_bb0825","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijpharm.2011.09.030","article-title":"Sodium tripolyphosphate: an excipient with intrinsic in vitro anti-Candida activity","volume":"421","author":"Palmeira-de-Oliveira","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2015.06.008_bb0830","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.msec.2012.09.007","article-title":"Clotrimazole nanoparticle gel for mucosal administration","volume":"33","author":"Esposito","year":"2013","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.addr.2015.06.008_bb0835","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/bit.21301","article-title":"Microparticles and nanoparticles for drug delivery","volume":"96","author":"Kohane","year":"2007","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.addr.2015.06.008_bb0840","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2478\/acph-2013-0027","article-title":"Bioadhesive vaginal tablets containing spray dried microspheres loaded with clotrimazole for treatment of vaginal candidiasis","volume":"63","author":"Gupta","year":"2013","journal-title":"Acta Pharma."},{"key":"10.1016\/j.addr.2015.06.008_bb0845","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ejps.2008.12.009","article-title":"Polymer-lipid based mucoadhesive microspheres prepared by spray-congealing for the vaginal delivery of econazole nitrate","volume":"36","author":"Albertini","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2015.06.008_bb0850","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.carbpol.2013.01.005","article-title":"Novel microparticulate systems for the vaginal delivery of nystatin: development and characterization","volume":"94","author":"Martin-Villena","year":"2013","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.addr.2015.06.008_bb0855","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.msec.2012.12.040","article-title":"Clotrimazole-loaded Eudragit(R) RS100 nanocapsules: preparation, characterization and in vitro evaluation of antifungal activity against Candida species","volume":"33","author":"Santos","year":"2013","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.addr.2015.06.008_bb0860","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.addr.2005.09.019","article-title":"Dendrimer biocompatibility and toxicity","volume":"57","author":"Duncan","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2015.06.008_bb0865","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/QAD.0b013e328346bd3e","article-title":"Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004)","volume":"25","author":"McGowan","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.addr.2015.06.008_bb0870","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024095","article-title":"SPL7013 Gel (VivaGel(R)) retains potent HIV-1 and HSV-2 inhibitory activity following vaginal administration in humans","volume":"6","author":"Price","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2015.06.008_bb0875","doi-asserted-by":"crossref","first-page":"530","DOI":"10.3390\/pharmaceutics6030530","article-title":"Characterization of commercially available vaginal lubricants: a safety perspective","volume":"6","author":"Cunha","year":"2014","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2015.06.008_bb0880","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2015.06.008_bb0885","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0928-0987(99)00033-0","article-title":"Liposomes containing drugs for treatment of vaginal infections","volume":"8","author":"Pavelic","year":"1999","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2015.06.008_bb0890","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijpharm.2014.06.016","article-title":"Chitosan-coated liposomes for topical vaginal therapy: assuring localized drug effect","volume":"472","author":"Joraholmen","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2015.06.008_bb0895","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1081\/DDC-54315","article-title":"Preparation, in vitro and in vivo evaluation of liposomal\/niosomal gel delivery systems for clotrimazole","volume":"31","author":"Ning","year":"2005","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.addr.2015.06.008_bb0900","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3109\/03639045.2012.670247","article-title":"Characterization of various deformable liposomes with metronidazole","volume":"39","author":"Vanic","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.addr.2015.06.008_bb0905","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijpharm.2005.05.022","article-title":"Characterisation and in vitro evaluation of bioadhesive liposome gels for local therapy of vaginitis","volume":"301","author":"Pavelic","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2015.06.008_bb0910","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.3109\/03639045.2012.707204","article-title":"Mucoadhesive nanoliposomal formulation for vaginal delivery of an antifungal","volume":"39","author":"Karimunnisa","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.addr.2015.06.008_bb0915","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ejpb.2012.04.007","article-title":"Chitosan-based drug delivery systems","volume":"81","author":"Bernkop-Schnurch","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2015.06.008_bb0920","article-title":"Development, optimization and evaluation of polymeric electrospun nanofiber: a tool for local delivery of fluconazole for management of vaginal candidiasis","volume":"1\u20138","author":"Sharma","year":"2014","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.addr.2015.06.008_bb0925","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/sti.2009.040386","article-title":"Prevalence and management of non-albicans vaginal candidiasis","volume":"86","author":"Hettiarachchi","year":"2010","journal-title":"Sex. Transm. Infect."},{"key":"10.1016\/j.addr.2015.06.008_bb0930","doi-asserted-by":"crossref","first-page":"727248","DOI":"10.1155\/2012\/727248","article-title":"In vitro anti-Candida activity of lidocaine and nitroglycerin: alone and combined","volume":"2012","author":"Palmeira-de-Oliveira","year":"2012","journal-title":"Infect. Dis. Obstet. Gynecol."},{"key":"10.1016\/j.addr.2015.06.008_bb0935","doi-asserted-by":"crossref","first-page":"E135","DOI":"10.1086\/324589","article-title":"Antifungal activity against Candida species of the selective serotonin-reuptake inhibitor, sertraline","volume":"33","author":"Lass-Florl","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.addr.2015.06.008_bb0940","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1128\/AAC.02623-13","article-title":"Anti-Candida activity of fluoxetine alone and combined with fluconazole: a synergistic action against fluconazole-resistant strains","volume":"58","author":"Oliveira","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2015.06.008_bb0945","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000338899","article-title":"In vitro assessment of gentian violet anti-Candida activity","volume":"74","author":"Gomes-de-Elvas","year":"2012","journal-title":"Gynecol. Obstet. Investig."},{"key":"10.1016\/j.addr.2015.06.008_bb0950","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.2174\/092986711795843182","article-title":"Aspartic protease inhibitors as potential anti-Candida albicans drugs: impacts on fungal biology, virulence and pathogenesis","volume":"18","author":"Braga-Silva","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.addr.2015.06.008_bb0955","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/jphp.12240","article-title":"Evaluation of efficacy, pharmacokinetics and tolerability of peptidomimetic aspartic proteinase inhibitors as cream formulation in experimental vaginal candidiasis","volume":"66","author":"De Bernardis","year":"2014","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.addr.2015.06.008_bb0960","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000332398","article-title":"A comparison of dequalinium chloride vaginal tablets (Fluomizin(R)) and clindamycin vaginal cream in the treatment of bacterial vaginosis: a single-blind, randomized clinical trial of efficacy and safety","volume":"73","author":"Weissenbacher","year":"2012","journal-title":"Gynecol. Obstet. Investig."},{"key":"10.1016\/j.addr.2015.06.008_bb0965","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijgo.2012.08.022","article-title":"A multicenter, double-blind, randomized, placebo-controlled study of rifaximin for the treatment of bacterial vaginosis","volume":"120","author":"Donders","year":"2013","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.addr.2015.06.008_bb0970","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/01.OGX.0000068791.04785.8D","article-title":"Common complementary and alternative therapies for yeast vaginitis and bacterial vaginosis: a systematic review","volume":"58","author":"Van Kessel","year":"2003","journal-title":"Obstet. Gynecol. Surv."},{"key":"10.1016\/j.addr.2015.06.008_bb0975","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1055\/s-0032-1328326","article-title":"Phytotherapy and women's reproductive health: the Cameroonian perspective","volume":"79","author":"Njamen","year":"2013","journal-title":"Planta Med."},{"key":"10.1016\/j.addr.2015.06.008_bb0980","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.taap.2009.12.005","article-title":"Assessment of herbal medicinal products: challenges, and opportunities to increase the knowledge base for safety assessment","volume":"243","author":"Jordan","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.addr.2015.06.008_bb0985","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3390\/pharmaceutics6040543","article-title":"What do Portuguese women prefer regarding vaginal products? Results from a cross-sectional web-based survey","volume":"6","author":"Palmeira-de-Oliveira","year":"2014","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2015.06.008_bb0990","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.2174\/138955709789878150","article-title":"Anti-Candida activity of essential oils","volume":"9","author":"Palmeira-de-Oliveira","year":"2009","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.addr.2015.06.008_bb0995","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1046\/j.1365-2672.1999.00780.x","article-title":"Antimicrobial activity of essential oils and other plant extracts","volume":"86","author":"Hammer","year":"1999","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.addr.2015.06.008_bb1000","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.2174\/09298673113209990007","article-title":"Are plant extracts a potential therapeutic approach for genital infections?","volume":"20","author":"Palmeira-de-Oliveira","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.addr.2015.06.008_bb1005","series-title":"Flavours and Fragrances: Chemistry","first-page":"87","article-title":"Bioactivity of essential oils and their components","author":"Koroch","year":"2007"},{"key":"10.1016\/j.addr.2015.06.008_bb1010","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/jac\/42.5.591","article-title":"In-vitro activity of essential oils, in particular Melaleuca alternifolia (tea tree) oil and tea tree oil products, against Candida spp.","volume":"42","author":"Hammer","year":"1998","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.addr.2015.06.008_bb1015","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1128\/AAC.43.1.196","article-title":"In vitro susceptibilities of lactobacilli and organisms associated with bacterial vaginosis to Melaleuca alternifolia (tea tree) oil","volume":"43","author":"Hammer","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2015.06.008_bb1020","first-page":"279","article-title":"Activites antagonistes, in vitro, of some essential oils and natural volatile compounds vis a vis the growth of Trichomonas vaginalis","volume":"67","author":"Viollon","year":"1996","journal-title":"Fitoterapia"},{"key":"10.1016\/j.addr.2015.06.008_bb1025","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/ptr.1348","article-title":"Chemical and biological evaluation of the essential oils of different Melaleuca species","volume":"18","author":"Farag","year":"2004","journal-title":"Phytother. Res."},{"key":"10.1016\/j.addr.2015.06.008_bb1030","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1472-765X.2003.01375.x","article-title":"Antimycotic activity of Melaleuca alternifolia essential oil and its major components","volume":"37","author":"Oliva","year":"2003","journal-title":"Lett. Appl. Microbiol."},{"key":"10.1016\/j.addr.2015.06.008_bb1035","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/jac\/dkh243","article-title":"Antifungal effects of Melaleuca alternifolia (tea tree) oil and its components on Candida albicans, Candida glabrata and Saccharomyces cerevisiae","volume":"53","author":"Hammer","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.addr.2015.06.008_bb1040","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ejpb.2006.05.006","article-title":"In vitro studies on release and human skin permeation of Australian tea tree oil (TTO) from topical formulations","volume":"64","author":"Reichling","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2015.06.008_bb1045","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/jphp.12334","article-title":"Essential oils and their constituents as skin penetration enhancer for transdermal drug delivery: a review","volume":"67","author":"Herman","year":"2015","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.addr.2015.06.008_bb1050","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1046\/j.1472-765X.1999.00605.x","article-title":"In-vitro antimicrobial activity and chemical composition of Sardinian Thymus essential oils","volume":"29","author":"Cosentino","year":"1999","journal-title":"Lett. Appl. Microbiol."},{"key":"10.1016\/j.addr.2015.06.008_bb1055","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/ptr.1594","article-title":"Antifungal effect of various essential oils against Candida albicans. Potentiation of antifungal action of amphotericin B by essential oil from Thymus vulgaris","volume":"18","author":"Giordani","year":"2004","journal-title":"Phytother. Res."},{"key":"10.1016\/j.addr.2015.06.008_bb1060","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1468-3083.2004.00886.x","article-title":"Antifungal activity of Thymus oils and their major compounds","volume":"18","author":"Pina-Vaz","year":"2004","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.addr.2015.06.008_bb1065","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jep.2012.01.029","article-title":"The anti-Candida activity of Thymbra capitata essential oil: effect upon pre-formed biofilm","volume":"140","author":"Palmeira-de-Oliveira","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.addr.2015.06.008_bb1070","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/13880200802436232","article-title":"Antifungal activity of a gel containing Thymus vulgaris essential oil against Candida species commonly involved in vulvovaginal candidosis","volume":"47","author":"das Neves","year":"2009","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.addr.2015.06.008_bb1075","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijgo.2007.11.010","article-title":"Zataria multiflora cream for the treatment of acute vaginal candidiasis","volume":"101","author":"Khosravi","year":"2008","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.addr.2015.06.008_bb1080","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.phymed.2008.08.004","article-title":"A comparative study of the therapeutic effects of the Zataria multiflora vaginal cream and metronidazole vaginal gel on bacterial vaginosis","volume":"15","author":"Simbar","year":"2008","journal-title":"Phytomedicine"},{"key":"10.1016\/j.addr.2015.06.008_bb1085","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.trstmh.2008.09.012","article-title":"Phase II clinical trial with Praneem polyherbal tablets for assessment of their efficacy in symptomatic women with abnormal vaginal discharge (an ICMR task force study)","volume":"103","author":"Sharma","year":"2009","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.addr.2015.06.008_bb1090","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/AOG.0b013e31820b07d5","article-title":"Alternative therapies in women with chronic vaginitis","volume":"117","author":"Nyirjesy","year":"2011","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.addr.2015.06.008_bb1095","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.fitote.2006.03.014","article-title":"In vitro antifungal activities of Allium cepa, Allium sativum and ketoconazole against some pathogenic yeasts and dermatophytes","volume":"77","author":"Shams-Ghahfarokhi","year":"2006","journal-title":"Fitoterapia"},{"key":"10.1016\/j.addr.2015.06.008_bb1100","first-page":"343","article-title":"Investigating the therapeutic effect of vaginal cream containing garlic and thyme compared to clotrimazole cream for the treatment of mycotic vaginitis","volume":"15","author":"Bahadoran","year":"2010","journal-title":"Iran. J. Nurs. Midwifery Res."},{"key":"10.1016\/j.addr.2015.06.008_bb1105","series-title":"Report of a Joint FAO\/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk With Live Lactic Acid Bacteria. American C\u00f3rdoba Park Hotel, C\u00f3rdoba, Argentina, 1\u20134 October","author":"FAO\/WHO","year":"2001"},{"key":"10.1016\/j.addr.2015.06.008_bb1110","first-page":"1","article-title":"Pharmabiotics: bioactives from mining host\u2013microbe\u2013dietary interactions","volume":"1","author":"Shanahan","year":"2009","journal-title":"Funct. Food Rev."},{"key":"10.1016\/j.addr.2015.06.008_bb1115","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1286-4579(00)00313-0","article-title":"Role played by lactobacilli in controlling the population of vaginal pathogens","volume":"2","author":"Boris","year":"2000","journal-title":"Microbes Infect."},{"key":"10.1016\/j.addr.2015.06.008_bb1120","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2174\/157340408786848214","article-title":"Advances in the knowledge and clinical applications of lactic acid bacteria as probiotics in the urogenital tract","volume":"4","author":"Nader-Macias","year":"2008","journal-title":"Curr. Women's Health Rev."},{"key":"10.1016\/j.addr.2015.06.008_bb1125","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/jac\/dkl246","article-title":"Probiotics for prevention of recurrent vulvovaginal candidiasis: a review","volume":"58","author":"Falagas","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.addr.2015.06.008_bb1130","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1423-0127-19-58","article-title":"Probiotic lactobacillus and estrogen effects on vaginal epithelial gene expression responses to Candida albicans","volume":"19","author":"Wagner","year":"2012","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.addr.2015.06.008_bb1135","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0939-6411(00)00121-1","article-title":"Technological and biological evaluation of tablets containing different strains of lactobacilli for vaginal administration","volume":"50","author":"Maggi","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2015.06.008_bb1140","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1128\/AAC.02542-13","article-title":"Sustained delivery of commensal bacteria from pod-intravaginal rings","volume":"58","author":"Gunawardana","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2015.06.008_bb1145","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.clinthera.2008.03.013","article-title":"Use of Lactobacillus probiotics for bacterial genitourinary infections in women: a review","volume":"30","author":"Barrons","year":"2008","journal-title":"Clin. Ther."},{"key":"10.1016\/j.addr.2015.06.008_bb1150","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/bmj.38210.494977.DE","article-title":"Effect of lactobacillus in preventing post-antibiotic vulvovaginal candidiasis: a randomised controlled trial","volume":"329","author":"Pirotta","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.addr.2015.06.008_bb1155","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s12602-014-9176-0","article-title":"Local probiotic therapy for vaginal Candida albicans infections","volume":"7","author":"Kovachev","year":"2015","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"10.1016\/j.addr.2015.06.008_bb1160","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ejogrb.2014.09.018","article-title":"Lactobacillus plantarum P17630 for preventing Candida vaginitis recurrence: a retrospective comparative study","volume":"182","author":"De Seta","year":"2014","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.addr.2015.06.008_bb1165","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1159\/000314016","article-title":"Effect of lyophilized lactobacilli and 0.03mg estriol (Gynoflor(R)) on vaginitis and vaginosis with disrupted vaginal microflora: a multicenter, randomized, single-blind, active-controlled pilot study","volume":"70","author":"Donders","year":"2010","journal-title":"Gynecol. Obstet. Investig."},{"issue":"Suppl.","key":"10.1016\/j.addr.2015.06.008_bb1170","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1097\/MCG.0b013e3182684d71","article-title":"Effectiveness of the association of 2 probiotic strains formulated in a slow release vaginal product, in women affected by vulvovaginal candidiasis: a pilot study","volume":"46","author":"Vicariotto","year":"2012","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.addr.2015.06.008_bb1175","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.anaerobe.2004.12.002","article-title":"Prebiotic effects of oligosaccharides on selected vaginal lactobacilli and pathogenic microorganisms","volume":"11","author":"Rousseau","year":"2005","journal-title":"Anaerobe"},{"key":"10.1016\/j.addr.2015.06.008_bb1180","doi-asserted-by":"crossref","first-page":"147867","DOI":"10.1155\/2012\/147867","article-title":"Safety and efficacy of an intravaginal prebiotic gel in the prevention of recurrent bacterial vaginosis: a randomized double-blind study","volume":"2012","author":"Coste","year":"2012","journal-title":"Obstet. Gynecol. Int."},{"key":"10.1016\/j.addr.2015.06.008_bb1185","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1139\/w98-068","article-title":"Effect of nutrient composition on the in vitro growth of urogenital lactobacilli and uropathogens","volume":"44","author":"Reid","year":"1998","journal-title":"Can. J. Microbiol."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X15001283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X15001283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T12:38:24Z","timestamp":1652791104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X15001283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":237,"alternative-id":["S0169409X15001283"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2015.06.008","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New strategies for local treatment of vaginal infections","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2015.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}